Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shenzhen - Delayed Quote CNY

Double Medical Technology Inc. (002901.SZ)

Compare
34.37
+0.63
+(1.87%)
At close: 3:04:48 PM GMT+8
Loading Chart for 002901.SZ
  • Previous Close 33.74
  • Open 32.92
  • Bid 34.35 x --
  • Ask 34.37 x --
  • Day's Range 33.56 - 34.86
  • 52 Week Range 21.78 - 36.97
  • Volume 2,671,400
  • Avg. Volume 1,993,690
  • Market Cap (intraday) 14.23B
  • Beta (5Y Monthly) 0.22
  • PE Ratio (TTM) 71.60
  • EPS (TTM) 0.48
  • Earnings Date --
  • Forward Dividend & Yield 0.25 (0.74%)
  • Ex-Dividend Date Jun 24, 2024
  • 1y Target Est 41.00

Double Medical Technology Inc. provides services, technologies, and devices in the areas of orthopedics, wound management, neurosurgery, and general surgery in China. It also exports its products to approximately 50 countries and regions, including European Union, Russia, South America, Australia, Southeast Asia, the Middle East, and South Africa. The company was formerly known as Xiamen Da Bo Ying Jing Medical Equipment Company Limited. Double Medical Technology Inc. was founded in 2004 and is based in Xiamen, China.

www.double-medical.com

4,033

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 002901.SZ

View More

Performance Overview: 002901.SZ

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002901.SZ
11.45%
SSE Composite Index (000001.SS)
0.01%

1-Year Return

002901.SZ
17.61%
SSE Composite Index (000001.SS)
11.31%

3-Year Return

002901.SZ
9.85%
SSE Composite Index (000001.SS)
4.26%

5-Year Return

002901.SZ
47.62%
SSE Composite Index (000001.SS)
20.89%

Compare To: 002901.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 002901.SZ

View More

Valuation Measures

As of 3/27/2025
  • Market Cap

    13.97B

  • Enterprise Value

    13.08B

  • Trailing P/E

    69.80

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.34

  • Price/Book (mrq)

    4.42

  • Enterprise Value/Revenue

    6.75

  • Enterprise Value/EBITDA

    49.14

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.38%

  • Return on Assets (ttm)

    2.43%

  • Return on Equity (ttm)

    7.17%

  • Revenue (ttm)

    1.94B

  • Net Income Avi to Common (ttm)

    201.13M

  • Diluted EPS (ttm)

    0.48

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.26B

  • Total Debt/Equity (mrq)

    11.41%

  • Levered Free Cash Flow (ttm)

    -69.08M

Research Analysis: 002901.SZ

View More

People Also Watch